18:41

Expert Perspectives: Lung Cancer

HMP Education

19:27

Immunotherapy in NSCLC - Promises and Challenges

HMP Education

22:07

Emerging options in radiotherapy

HMP Education

14:00

Locally advanced NSCLC - State of Systemic Therapy

HMP Education

14:35

Next Generation Clinical Trials in NSCLC (ALCHEMIST, MASTER, NCI MATCH, etc.)

HMP Education

33:52

Keynote Lecture: Targeted Therapies in Lung Cancer 2.0 – Advances and Promises

HMP Education

16:22

DEBATE: Drug of choice for exon 19 del EGFR mutant NSCLC - Afatinib

HMP Education

13:26

DEBATE: Drug of choice for exon 19 del EGFR mutant NSCLC - Any EGFR TKI

HMP Education

13:28

DEBATE: ALK positive NSCLC - Front line therapy - Crizotinib

HMP Education

11:38

DEBATE: ALK positive NSCLC - Front line therapy - Ceritinib

HMP Education

12:05

DEBATE: Molecular profiling beyond EGFR/ALK - Not for everyone

HMP Education

16:27

DEBATE: Molecular profiling beyond EGFR/ALK - Must be the standard

HMP Education

13:19

DEBATE: Extensive stage SCLC - Thoracic Radiation? - Yes

HMP Education

8:37

DEBATE: Extensive stage SCLC - Thoracic Radiation? - No

HMP Education

13:56

Adjuvant therapy - Chemotherapy issues

HMP Education

14:30

Adjuvant therapy for EGFR mutant NSCLC

HMP Education

12:05

Oligometastatic NSCLC

HMP Education